Fulcrum Therapeutics FULC
NASDAQ FULC
$3.74 +0.02 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

Fulcrum Therapeutics (FULC) Return on Equity [ROE] (2019 - 2026)

Updated

Fulcrum Therapeutics (FULC) reported Return on Equity [ROE] of -29.83% for Q2 2026, up 8.46 percentage points from -38.28% a year earlier but down 4.46 percentage points from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Fulcrum Therapeutics posted Return on Equity [ROE] of -28.64%, down 19.48 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of +49.91 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -9.16% in FY2024 (+41.82 pp), -50.98% in FY2023 (+3.86 pp), -54.84% in FY2022 (-1.99 pp) and -52.85% in FY2021 (+25.70 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -59.76% in Q2 2022 and a high of -5.29% in Q1 2025.
  • Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of +3.09 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q1 2025 (a gain of 44.87 percentage points); the low point was Q3 2025 (a drop of 28.02 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -25.37% (Q1 2026), -30.97% (Q4 2025) and -39.49% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Fulcrum Therapeutics 283.78 Mn -59.56 Mn - -26.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.60%
Mar 31, 2026 -22.48%
Dec 31, 2025 -27.34%
Sep 30, 2025 -34.53%
Jun 30, 2025 -32.86%
Mar 31, 2025 0.00%
Dec 31, 2024 -3.78%
Sep 30, 2024 -6.27%
Jun 30, 2024 -7.96%
Mar 31, 2024 -44.21%
Dec 31, 2023 -39.41%
Sep 30, 2023 -37.17%
Jun 30, 2023 -34.48%
Mar 31, 2023 -43.73%
Dec 31, 2022 -52.47%
Sep 30, 2022 -56.55%
Jun 30, 2022 -60.16%
Mar 31, 2022 -45.35%
Dec 31, 2021 -36.75%
Sep 30, 2021 -44.04%
API Access

Fulcrum Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=FULC&period=max&api_key=YOUR_API_KEY